Treatment of children with pulmonary hypertension. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK.
about
First-in-child use of the oral selective prostacyclin IP receptor agonist selexipag in pulmonary arterial hypertensionBiocomparison Study of Adult and Paediatric Dose Strengths of the Prostacyclin Receptor Agonist Selexipag.Executive summary. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK.First-in-child use of the oral soluble guanylate cyclase stimulator riociguat in pulmonary arterial hypertension.Diagnostics, monitoring and outpatient care in children with suspected pulmonary hypertension/paediatric pulmonary hypertensive vascular disease. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The EurATS Core Curriculum 2017: Part II. Pediatric Pulmonary Medicine.Future Applications of the Selective Prostacyclin (IP) Receptor Agonist Selexipag in Pediatric Pulmonary Hypertension.Heartbeat: Imaging complex vascular anatomy in congenital heart disease.Pulmonary hypertension associated with acute or chronic lung diseases in the preterm and term neonate and infant. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK.Pulmonary hypertension in the intensive care unit. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK.Pulmonary hypertension in children with congenital heart disease (PAH-CHD, PPHVD-CHD). Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsCommentary: Echocardiographic Evaluation of Pulmonary Pressures and Right Ventricular Function after Pediatric Cardiac Surgery: A Simple Approach for the Intensivist.Should we use the oral selective IP receptor agonist selexipag off-label in children with pulmonary arterial hypertension?
P2860
Q33168719-75381032-4BCB-442C-AFB9-84CF93AEB21BQ38375177-D9C43D61-F09B-434A-90ED-563B3766D52DQ38800327-BC517053-10CC-4E69-9D7C-A0645DDEC6A3Q47110570-07777DD8-9306-48DE-90BC-B5392E2C41D8Q47443854-1F58C47E-3C83-4D28-9288-777D022FF6C8Q47787813-C26D7A1C-6C9E-462E-BA53-EA81968A58A0Q48001187-3BE0EDBC-8487-48AF-A348-C4481D4EC6C9Q48305547-55E26073-5A57-4C36-A8F6-A249B0B7445EQ50522527-2CDC4438-D64F-4865-8C96-47993FE47A0DQ50672726-03DC4650-CA5B-40B8-9E77-84C1A9FBAE4CQ50672734-7AC62021-7638-4B0D-9331-596DC426D8FCQ55003237-755A13DE-3A4C-4C7F-B117-9F042F63221FQ57178903-73290626-1077-4C9E-B31B-6FCA9627A0D8
P2860
Treatment of children with pulmonary hypertension. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Treatment of children with pul ...... k, endorsed by ISHLT and DGPK.
@en
Treatment of children with pul ...... k, endorsed by ISHLT and DGPK.
@nl
type
label
Treatment of children with pul ...... k, endorsed by ISHLT and DGPK.
@en
Treatment of children with pul ...... k, endorsed by ISHLT and DGPK.
@nl
prefLabel
Treatment of children with pul ...... k, endorsed by ISHLT and DGPK.
@en
Treatment of children with pul ...... k, endorsed by ISHLT and DGPK.
@nl
P2860
P1433
P1476
Treatment of children with pul ...... k, endorsed by ISHLT and DGPK.
@en
P2093
Christian Apitz
Georg Hansmann
P2860
P304
P356
10.1136/HEARTJNL-2015-309103
P407
P478
102 Suppl 2
P577
2016-05-01T00:00:00Z